4 doctors weighed in:
What percentage of MS patients are on tysabri (natalizumab)? Is there a big chance of bad side effects?
4 doctors weighed in

Dr. Gael Yonnet
Neurology
2 doctors agree
In brief: Answer continues...
If, you have tested negative for jc virus antibodies, your chance of getting pml is around 0.
09/1, 000. On the other hand, if you have tested positive for jc virus antibodies, have been on tysabri (natalizumab) therapy for over two years and have prior exposure to immunosuppressant therapies, such as azathioprine, methotrexate, micophenolate, Cyclophosphamide or mitoxantrone, your risk becomes 11.1/1000.

In brief: Answer continues...
If, you have tested negative for jc virus antibodies, your chance of getting pml is around 0.
09/1, 000. On the other hand, if you have tested positive for jc virus antibodies, have been on tysabri (natalizumab) therapy for over two years and have prior exposure to immunosuppressant therapies, such as azathioprine, methotrexate, micophenolate, Cyclophosphamide or mitoxantrone, your risk becomes 11.1/1000.
Dr. Gael Yonnet
Dr. Gael Yonnet
Thank
Dr. Gael Yonnet
Neurology
1 doctor agrees
In brief: See answer below
The percentage of patients on tysabri (natalizumab) vary from clinic to clinic.
Tysabri (natalizumab) is usually reserved for use as a second line therapy. It is however the best available treatment for ms patients today (6/23/12). The main side effect you will hear about is pml. The risk for development of pml depends on duration of tysabri (natalizumab) treatment, prior exposure to immunosuppressant therapies and jc virus status.

In brief: See answer below
The percentage of patients on tysabri (natalizumab) vary from clinic to clinic.
Tysabri (natalizumab) is usually reserved for use as a second line therapy. It is however the best available treatment for ms patients today (6/23/12). The main side effect you will hear about is pml. The risk for development of pml depends on duration of tysabri (natalizumab) treatment, prior exposure to immunosuppressant therapies and jc virus status.
Dr. Gael Yonnet
Dr. Gael Yonnet
Thank
In brief: See below
Not clear to me as to percentage of the various agents, but figures from Biogen suggest over 100,000 worldwide patents and at least 450 cases of PML.
This can be managed readily by a risk factor blood test, called the anti-JCV antibody index. Risk of PML runs from 1in 90 to 1 in 40,000. Risk increases with prior use of immunosuppressant agent, Tysabri (natalizumab) >2yrs, positive blood test.

In brief: See below
Not clear to me as to percentage of the various agents, but figures from Biogen suggest over 100,000 worldwide patents and at least 450 cases of PML.
This can be managed readily by a risk factor blood test, called the anti-JCV antibody index. Risk of PML runs from 1in 90 to 1 in 40,000. Risk increases with prior use of immunosuppressant agent, Tysabri (natalizumab) >2yrs, positive blood test.
Dr. Bennett Machanic
Dr. Bennett Machanic
Thank
Get help from a real doctor now
Dr. Eric Weisman
Board Certified, Neurology
32 years in practice
9M people helped
Continue
107,000 doctors available
Read more answers from doctors